Skip to main content
Premium Trial:

Request an Annual Quote

Velcura Therapeutics, Scripps-PARC Institute for Advanced Biomedical Sciences


Velcura Therapeutics has developed a custom Affymetrix GeneChip array for monitoring changes in gene expression during human bone formation. The array will be used for researching osteoporosis and other bone diseases. The custom chip is available solely to Velcura for use within its own research labs and to Velcura’s strategic partners.

The Scripps-PARC Institute for Advanced Biomedical Sciences, a joint venture of the Scripps Research Institute and the Palo Alto Research Center, has developed a nanocalorimeter that it believes will enable researchers to design new drugs more quickly. The enthalpy array technology uses 250 nanoliter droplets of a test compound on 96-detector arrays and allows researchers to characterize larger numbers of samples in a shorter amount of time than traditional methods, the partners said.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.